NEW YORK, NY - 
(NewMediaWire) - May 02, 2022 - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE: TDOC).
There is no cost or obligation to you.
Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.
On April 27, 2022, Teladoc announced its first quarter 2022 financial results, including revenue of $565.4 million, which missed consensus estimates by $3.23 million, and “[n]et loss per share of $41.58, primarily driven by [a] non-cash goodwill impairment charge of $6.6 billion or $41.11 per share[,]” prompting multiple analyst downgrades on the Company’s stock.
On this news, Teladoc’s stock price fell sharply during intraday trading on April 28, 2022.
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.View the original release on www.newmediawire.com
